Amanote Research
Register
Sign In
Dose-Adjusted Epoch for Lymphoma-Associated Hemophagocytic Lymphohistiocytosis: A Stone Two Birds
Hematological Oncology
- United Kingdom
doi 10.1002/hon.218_2631
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Cancer Research
Oncology
Hematology
Date
June 1, 2019
Authors
W. Xu
J. Liang
L. Wang
H. Zhu
Y. Xia
W. Wu
L. Fan
J. Li
Publisher
Wiley
Related search
Hemophagocytic Lymphohistiocytosis in a Patient With Classical Hodgkin Lymphoma
Case Reports in Hematology
Hemophagocytic Lymphohistiocytosis
High Rate of Morbid Central Line Associated Complications During Treatment With Dose-Adjusted R-Epoch Therapy for Non-Hodgkin Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Acquired Hemophagocytic Lymphohistiocytosis Associated With Malignant Disease
Hemophagocytic Lymphohistiocytosis With B-Cell Lymphoma, a Rare Lethal Cause for Fulminant Hepatic Failure
Journal of Translational Science
Ibrutinib‐associated Hemophagocytic Lymphohistiocytosis: A Case Series From Johns Hopkins
American Journal of Hematology
Hematology
Hemophagocytic Lymphohistiocytosis in Association With Primary Cutaneous Anaplastic Large Cell Lymphoma
Case Reports in Hematology
Hemophagocytic Lymphohistiocytosis in a Young Child
International Journal Of Medical Science And Clinical Invention
A Systematic Review of Malignancy-Associated Hemophagocytic Lymphohistiocytosis That Needs More Attentions
Oncotarget
Oncology